PPiper Sandler TTesla · TSLA

Piper Sandler Reiterates Tesla’s $400 PT

Jun 10, 2025· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$400
Previous
Implied upside
+30%

Piper Sandler reiterated on June 10, 2025, an ‘Overweight’ rating on Tesla, with a $400 price target.


There were two developments in our coverage that warrant special attention today:

  1. Driverless Teslas have been spotted on the streets of Austin, TX
  1. Kelley Blue Book released data for new car pricing (see chart on page 2)

These may seem like unrelated data points, but they’re not. See below for our rationale.

Bottom line: a key component of our TSLA thesis has officially begun playing out. We expect the stock to sustain upward momentum in the coming weeks, as more information is disclosed (pending any high-profile robo-taxi accidents, which would likely be met with violent downside). We reiterate our Overweight rating.


RISKS TO ACHIEVEMENT OF PT & RECOMMENDATION

Production delays, raw material pricing volatility, product defects and recalls, supply chain disruptions, slow adoption of electric vehicles.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.